Harrow Health, Inc. 8.625% Senior Notes due 2026
Harrow Health, Inc. 8.625% Senior Notes due 2026 HROWL Peers
See (HROWL) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HROWL | $25.24 | -0.04% | 1.1B | N/A | N/A | N/A |
| ONC | $255.86 | -0.44% | 29.1B | -70.10 | -$3.65 | N/A |
| INSM | $73.60 | +1.18% | 13.4B | -12.41 | -$5.93 | N/A |
| WBA | $11.25 | +0.04% | 9.7B | -1.68 | -$6.69 | +4.44% |
| LFMDP | $23.20 | -0.22% | 1.1B | -10.28 | -$2.26 | N/A |
| HROWM | $25.98 | -0.21% | 1.1B | N/A | N/A | +11.42% |
| LFMD | $12.72 | +5.30% | 578.1M | -38.55 | -$0.33 | N/A |
| HITI | $2.36 | +1.07% | 191M | -39.33 | -$0.06 | N/A |
| PETS | $3.96 | -0.25% | 81.8M | 396.00 | $0.01 | N/A |
| YI | $8.14 | -2.57% | 70.6M | -7.76 | -$1.05 | N/A |
Stock Comparison
HROWL vs ONC Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, ONC has a market cap of 29.1B. Regarding current trading prices, HROWL is priced at $25.24, while ONC trades at $255.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas ONC's P/E ratio is -70.10. In terms of profitability, HROWL's ROE is -0.36%, compared to ONC's ROE of -0.12%. Regarding short-term risk, HROWL is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs INSM Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, INSM has a market cap of 13.4B. Regarding current trading prices, HROWL is priced at $25.24, while INSM trades at $73.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas INSM's P/E ratio is -12.41. In terms of profitability, HROWL's ROE is -0.36%, compared to INSM's ROE of -4.47%. Regarding short-term risk, HROWL is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs WBA Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, WBA has a market cap of 9.7B. Regarding current trading prices, HROWL is priced at $25.24, while WBA trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas WBA's P/E ratio is -1.68. In terms of profitability, HROWL's ROE is -0.36%, compared to WBA's ROE of -0.55%. Regarding short-term risk, HROWL is more volatile compared to WBA. This indicates potentially higher risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFMDP Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, LFMDP has a market cap of 1.1B. Regarding current trading prices, HROWL is priced at $25.24, while LFMDP trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -10.28. In terms of profitability, HROWL's ROE is -0.36%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, HROWL is less volatile compared to LFMDP. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs HROWM Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, HROWM has a market cap of 1.1B. Regarding current trading prices, HROWL is priced at $25.24, while HROWM trades at $25.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas HROWM's P/E ratio is N/A. In terms of profitability, HROWL's ROE is -0.36%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, HROWL is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFMD Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, LFMD has a market cap of 578.1M. Regarding current trading prices, HROWL is priced at $25.24, while LFMD trades at $12.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -38.55. In terms of profitability, HROWL's ROE is -0.36%, compared to LFMD's ROE of +2.33%. Regarding short-term risk, HROWL is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs HITI Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, HITI has a market cap of 191M. Regarding current trading prices, HROWL is priced at $25.24, while HITI trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas HITI's P/E ratio is -39.33. In terms of profitability, HROWL's ROE is -0.36%, compared to HITI's ROE of -0.05%. Regarding short-term risk, HROWL is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs PETS Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, PETS has a market cap of 81.8M. Regarding current trading prices, HROWL is priced at $25.24, while PETS trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas PETS's P/E ratio is 396.00. In terms of profitability, HROWL's ROE is -0.36%, compared to PETS's ROE of +0.00%. Regarding short-term risk, HROWL is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs YI Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, YI has a market cap of 70.6M. Regarding current trading prices, HROWL is priced at $25.24, while YI trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas YI's P/E ratio is -7.76. In terms of profitability, HROWL's ROE is -0.36%, compared to YI's ROE of +0.10%. Regarding short-term risk, HROWL is less volatile compared to YI. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs RNTX Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, RNTX has a market cap of 44.3M. Regarding current trading prices, HROWL is priced at $25.24, while RNTX trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas RNTX's P/E ratio is -0.69. In terms of profitability, HROWL's ROE is -0.36%, compared to RNTX's ROE of -0.80%. Regarding short-term risk, HROWL is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs RAD Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, HROWL is priced at $25.24, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas RAD's P/E ratio is -0.05. In terms of profitability, HROWL's ROE is -0.36%, compared to RAD's ROE of +2.76%. Regarding short-term risk, HROWL is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs MEDS Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, HROWL is priced at $25.24, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas MEDS's P/E ratio is -0.31. In terms of profitability, HROWL's ROE is -0.36%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, HROWL is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs NEUP Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, NEUP has a market cap of 12.9M. Regarding current trading prices, HROWL is priced at $25.24, while NEUP trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas NEUP's P/E ratio is 0.36. In terms of profitability, HROWL's ROE is -0.36%, compared to NEUP's ROE of +0.31%. Regarding short-term risk, HROWL is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs CJJD Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, HROWL is priced at $25.24, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas CJJD's P/E ratio is -0.46. In terms of profitability, HROWL's ROE is -0.36%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, HROWL is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs SSY Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, SSY has a market cap of 6.2M. Regarding current trading prices, HROWL is priced at $25.24, while SSY trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas SSY's P/E ratio is -2.26. In terms of profitability, HROWL's ROE is -0.36%, compared to SSY's ROE of +0.12%. Regarding short-term risk, HROWL is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs ATNFW Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, ATNFW has a market cap of 5.6M. Regarding current trading prices, HROWL is priced at $25.24, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas ATNFW's P/E ratio is N/A. In terms of profitability, HROWL's ROE is -0.36%, compared to ATNFW's ROE of -1.47%. Regarding short-term risk, HROWL is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs MDVL Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, HROWL is priced at $25.24, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas MDVL's P/E ratio is -0.05. In terms of profitability, HROWL's ROE is -0.36%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, HROWL is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFLYW Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, LFLYW has a market cap of 651K. Regarding current trading prices, HROWL is priced at $25.24, while LFLYW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFLYW's P/E ratio is -0.07. In terms of profitability, HROWL's ROE is -0.36%, compared to LFLYW's ROE of +0.34%. Regarding short-term risk, HROWL is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFLY Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, LFLY has a market cap of 470.6K. Regarding current trading prices, HROWL is priced at $25.24, while LFLY trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFLY's P/E ratio is -0.08. In terms of profitability, HROWL's ROE is -0.36%, compared to LFLY's ROE of +0.34%. Regarding short-term risk, HROWL is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs BIMI Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 1.1B. In comparison, BIMI has a market cap of 9.4K. Regarding current trading prices, HROWL is priced at $25.24, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas BIMI's P/E ratio is N/A. In terms of profitability, HROWL's ROE is -0.36%, compared to BIMI's ROE of -2.93%. Regarding short-term risk, HROWL is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for HROWL.